Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TCEB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSBP1L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNJ2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SREK1IP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
EXOSC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB22A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC4A11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100507564 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSD17B14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZXDB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIST1H2BB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C4orf48 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERCC8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF160 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RWDD2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPAIN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHD1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GATAD2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on